OBJECTIVE: Postprandial lipemia has been linked to atherosclerosis and inflammation. Because leukocyte activation is obligatory for atherogenesis, leukocyte activation by triglyceride-rich lipoproteins (TRLs) was investigated. METHODS AND RESULTS: The expression of CD11b and CD66b after incubation with glucose and native and artificial TRLs (NTRL and ATRL) in vivo and in vitro was evaluated by flowcytometry. Oral fat loading tests showed an increased expression of CD11b on monocytes and neutrophils and CD66b on neutrophils. In 11 volunteers, postprandial leukocytes became enriched with meal-derived fatty acids ([1-(13)C]16:0) suggesting uptake of exogenous fat. ApoB binding on leukocytes measured by flowcytometry in 65 subjects was highest on neutrophils and monocytes suggesting adherence of apoB-containing lipoproteins. Physiological concentrations of TRLs showed 62% increased neutrophil CD11b and a dose-dependent increased monocyte CD11b up to 84% in vitro. Incubations with lipid emulsions in the hypertriglyceridemic range showed a 5-fold increased monocyte CD11b expression, which was higher than the positive control (fMLP), and a dose-dependent 2- to 3-fold increased neutrophil CD11b and CD66b. The oxidative scavenger DMTU decreased the neutrophil CD66b expression by 36%. CONCLUSIONS: Acute hypertriglyceridemia is a leukocyte activator most likely by direct interaction between TRLs and leukocytes and uptake of fatty acids. TG-mediated leukocyte activation is an alternative proinflammatory and proatherogenic mechanism of hypertriglyceridemia in part associated to the generation of oxidative stress.
OBJECTIVE: Postprandial lipemia has been linked to atherosclerosis and inflammation. Because leukocyte activation is obligatory for atherogenesis, leukocyte activation by triglyceride-rich lipoproteins (TRLs) was investigated. METHODS AND RESULTS: The expression of CD11b and CD66b after incubation with glucose and native and artificial TRLs (NTRL and ATRL) in vivo and in vitro was evaluated by flowcytometry. Oral fat loading tests showed an increased expression of CD11b on monocytes and neutrophils and CD66b on neutrophils. In 11 volunteers, postprandial leukocytes became enriched with meal-derived fatty acids ([1-(13)C]16:0) suggesting uptake of exogenous fat. ApoB binding on leukocytes measured by flowcytometry in 65 subjects was highest on neutrophils and monocytes suggesting adherence of apoB-containing lipoproteins. Physiological concentrations of TRLs showed 62% increased neutrophil CD11b and a dose-dependent increased monocyte CD11b up to 84% in vitro. Incubations with lipid emulsions in the hypertriglyceridemic range showed a 5-fold increased monocyte CD11b expression, which was higher than the positive control (fMLP), and a dose-dependent 2- to 3-fold increased neutrophil CD11b and CD66b. The oxidative scavenger DMTU decreased the neutrophil CD66b expression by 36%. CONCLUSIONS: Acute hypertriglyceridemia is a leukocyte activator most likely by direct interaction between TRLs and leukocytes and uptake of fatty acids. TG-mediated leukocyte activation is an alternative proinflammatory and proatherogenic mechanism of hypertriglyceridemia in part associated to the generation of oxidative stress.
Authors: Nathan T Jenkins; Rian Q Landers; Sunny R Thakkar; Xiaoxuan Fan; Michael D Brown; Steven J Prior; Espen E Spangenburg; James M Hagberg Journal: J Physiol Date: 2011-09-19 Impact factor: 5.182
Authors: R Michael Gower; Huaizhu Wu; Greg A Foster; Sridevi Devaraj; Ishwarlal Jialal; Christie M Ballantyne; Anne A Knowlton; Scott I Simon Journal: Arterioscler Thromb Vasc Biol Date: 2010-10-28 Impact factor: 8.311
Authors: Ilvira M Khan; Yashashwi Pokharel; Razvan T Dadu; Dorothy E Lewis; Ron C Hoogeveen; Huaizhu Wu; Christie M Ballantyne Journal: J Clin Endocrinol Metab Date: 2016-08-30 Impact factor: 5.958
Authors: L Maria Belalcazar; David M Reboussin; Steven M Haffner; Ron C Hoogeveen; Andrea M Kriska; Dawn C Schwenke; Russell P Tracy; F Xavier Pi-Sunyer; Christie M Ballantyne Journal: Diabetes Care Date: 2010-08-03 Impact factor: 19.112
Authors: Michael Inouye; Kaisa Silander; Eija Hamalainen; Veikko Salomaa; Kennet Harald; Pekka Jousilahti; Satu Männistö; Johan G Eriksson; Janna Saarela; Samuli Ripatti; Markus Perola; Gert-Jan B van Ommen; Marja-Riitta Taskinen; Aarno Palotie; Emmanouil T Dermitzakis; Leena Peltonen Journal: PLoS Genet Date: 2010-09-09 Impact factor: 5.917
Authors: Lars Maegdefessel; Axel Schlitt; Susanna Pippig; Bernhard Schwaab; Kerstin Fingscheidt; Uwe Raaz; Michael Buerke; Harald Loppnow Journal: Vasc Health Risk Manag Date: 2009-10-12